SC 13G Filing

Company

UroGen Pharma Ltd.

Filed

September 15, 2023

Accession Number

0001172661-23-003255

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →